Find in Library

Increasing antimicrobial resistance (AMR) challenges conventional antibiotics, prompting the search for alternatives. Extracellular vesicles (EVs) from pasteurised cattle milk offer promise, due to their unique properties. This study investigates their efficacy against five pathogenic bacteria, including <i>Staphylococcus aureus</i> ATCC 25923, aiming to combat AMR and to develop new therapies. EVs were characterised and tested using various methods. Co-culture experiments with <i>S. aureus</i> showed significant growth inhibition, with colony-forming units decreasing from 2.4 × 10⁵ CFU/mL (single dose) to 7.4 × 10⁴ CFU/mL (triple doses) after 12 h. Milk EVs extended lag time (6 to 9 h) and increased generation time (2.8 to 4.8 h) dose-dependently, compared to controls. In conclusion, milk EVs exhibit dose-dependent inhibition against <i>S. aureus</i>, prolonging lag and generation times. Despite limitations, this suggests their potential in addressing AMR.